Our History
Started training in 1982 at the Bendix Corporation. Visited all manufactures of oxygen concentrators and liquid oxygen systems being certified on all models over the evolution of the industry. Operated Impact BioMedical Corp servicing thousands of oxygen concentrator products and parts from 1989 thru 2015. With 35 years of oxygen equipment experience we are launching a on-line service that will provide simplicity, value, and reliability for oxygen customers on the go.
Union Carbide Corporation (UCC) invented home medical oxygen concentrators in the late 1970s. Home medical oxygen concentrators began to be made in large numbers in the early 1980s. Prior to that time home medical oxygen therapy required the use of high pressure oxygen cylinders or small liquid cryogenic oxygen systems. Medicare switched from fee-for-service payment to a flat monthly rate for home oxygen therapy in the mid-1980s, causing the durable medical equipment (DME) industry to quickly embrace concentrators as a way to control costs. This reimbursement change dramatically decreased the number of home liquid medical oxygen systems in the US at that time. The number of manufacturers entering the oxygen concentrator market increased exponentially as a result of this change. UCC invented molecular sieve that made these devices possible in the 1950s. UCC also invented the first home medical liquid oxygen systems in the 1960s.
Started training in 1982 at the Bendix Corporation. Visited all manufactures of oxygen concentrators and liquid oxygen systems being certified on all models over the evolution of the industry. Operated Impact BioMedical Corp servicing thousands of oxygen concentrator products and parts from 1989 thru 2015. With 35 years of oxygen equipment experience we are launching a on-line service that will provide simplicity, value, and reliability for oxygen customers on the go.
Union Carbide Corporation (UCC) invented home medical oxygen concentrators in the late 1970s. Home medical oxygen concentrators began to be made in large numbers in the early 1980s. Prior to that time home medical oxygen therapy required the use of high pressure oxygen cylinders or small liquid cryogenic oxygen systems. Medicare switched from fee-for-service payment to a flat monthly rate for home oxygen therapy in the mid-1980s, causing the durable medical equipment (DME) industry to quickly embrace concentrators as a way to control costs. This reimbursement change dramatically decreased the number of home liquid medical oxygen systems in the US at that time. The number of manufacturers entering the oxygen concentrator market increased exponentially as a result of this change. UCC invented molecular sieve that made these devices possible in the 1950s. UCC also invented the first home medical liquid oxygen systems in the 1960s.
